Literature DB >> 34157276

Describing the Structural Phenotype of the Glaucomatous Optic Nerve Head Using Artificial Intelligence.

Satish K Panda1, Haris Cheong1, Tin A Tun2, Sripad K Devella1, Vijayalakshmi Senthil3, Ramaswami Krishnadas3, Martin L Buist4, Shamira Perera5, Ching-Yu Cheng6, Tin Aung6, Alexandre H Thiéry7, Michaël J A Girard8.   

Abstract

PURPOSE: To develop a novel deep-learning approach that can describe the structural phenotype of the glaucomatous optic nerve head (ONH) and can be used as a robust glaucoma diagnosis tool.
DESIGN: Retrospective, deep-learning approach diagnosis study.
METHOD: We trained a deep-learning network to segment 3 neural-tissue and 4 connective-tissue layers of the ONH. The segmented optical coherence tomography images were then processed by a customized autoencoder network with an additional parallel branch for binary classification. The encoder part of the autoencoder reduced the segmented optical coherence tomography images into a low-dimensional latent space (LS), whereas the decoder and the classification branches reconstructed the images and classified them as glaucoma or nonglaucoma, respectively. We performed principal component analysis on the latent parameters and identified the principal components (PCs). Subsequently, the magnitude of each PC was altered in steps and reported how it impacted the morphology of the ONH.
RESULTS: The image reconstruction quality and diagnostic accuracy increased with the size of the LS. With 54 parameters in the LS, the diagnostic accuracy was 92.0 ± 2.3% with a sensitivity of 90.0 ± 2.4% (at 95% specificity), and the corresponding Dice coefficient for the reconstructed images was 0.86 ± 0.04. By changing the magnitudes of PC in steps, we were able to reveal how the morphology of the ONH changes as one transitions from a "nonglaucoma" to a "glaucoma" condition.
CONCLUSIONS: Our network was able to identify novel biomarkers of the ONH for glaucoma diagnosis. Specifically, the structural features identified by our algorithm were found to be related to clinical observations of glaucoma.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34157276     DOI: 10.1016/j.ajo.2021.06.010

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Development of a β-Variational Autoencoder for Disentangled Latent Space Representation of Anterior Segment Optical Coherence Tomography Images.

Authors:  Kilhwan Shon; Kyung Rim Sung; Jiehoon Kwak; Joong Won Shin; Joo Yeon Lee
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

2.  Application of Deep Learning Methods for Binarization of the Choroid in Optical Coherence Tomography Images.

Authors:  Joshua Muller; David Alonso-Caneiro; Scott A Read; Stephen J Vincent; Michael J Collins
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

Review 3.  The Development and Clinical Application of Innovative Optical Ophthalmic Imaging Techniques.

Authors:  Palaiologos Alexopoulos; Chisom Madu; Gadi Wollstein; Joel S Schuman
Journal:  Front Med (Lausanne)       Date:  2022-06-30

4.  Artificial Intelligence in Eye Disease: Recent Developments, Applications, and Surveys.

Authors:  Jae-Ho Han
Journal:  Diagnostics (Basel)       Date:  2022-08-10

5.  Assessing Surface Shapes of the Optic Nerve Head and Peripapillary Retinal Nerve Fiber Layer in Glaucoma with Artificial Intelligence.

Authors:  Chhavi Saini; Lucy Q Shen; Louis R Pasquale; Michael V Boland; David S Friedman; Nazlee Zebardast; Mojtaba Fazli; Yangjiani Li; Mohammad Eslami; Tobias Elze; Mengyu Wang
Journal:  Ophthalmol Sci       Date:  2022-04-20

6.  Early Glaucoma Detection by Using Style Transfer to Predict Retinal Nerve Fiber Layer Thickness Distribution on the Fundus Photograph.

Authors:  Henry Shen-Lih Chen; Guan-An Chen; Jhen-Yang Syu; Lan-Hsin Chuang; Wei-Wen Su; Wei-Chi Wu; Jian-Hong Liu; Jian-Ren Chen; Su-Chen Huang; Eugene Yu-Chuan Kang
Journal:  Ophthalmol Sci       Date:  2022-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.